Texas Oncology PA North/Sammans Cancer Center — Dallas, Texas

Texas Oncology PA North/Sammans Cancer Center is a clinical research site located in Dallas, Texas, United States 75246.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Texas Oncology PA North/Sammans Cancer Center has participated in 1 clinical trials.

Therapeutic areas: HER-2 Gene Amplification.

Sponsors: Merrimack Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology PA North/Sammans Cancer Center?

Texas Oncology PA North/Sammans Cancer Center has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology PA North/Sammans Cancer Center conducted?

Texas Oncology PA North/Sammans Cancer Center has 1 clinical trials on record. Their work covers HER-2 Gene Amplification.

Is Texas Oncology PA North/Sammans Cancer Center accredited by Crixeo Health?

Texas Oncology PA North/Sammans Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Oncology PA North/Sammans Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.